Otrs AG
F:TR9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Otrs AG
F:TR9
|
DE |
|
Northeast Community Bancorp Inc
NASDAQ:NECB
|
US |
|
C
|
Cryo-Cell International Inc
AMEX:CCEL
|
US |
|
S
|
SaltX Technology Holding AB (publ)
STO:SALT B
|
SE |
|
S
|
Sharda Motor Industries Ltd
BSE:535602
|
IN |
|
E
|
ENF Technology Co Ltd
KOSDAQ:102710
|
KR |
|
B
|
Bri-Chem Corp
TSX:BRY
|
CA |
|
T
|
Tianjin Binhai Energy & Development Co Ltd
SZSE:000695
|
CN |
|
BOE Technology Group Co Ltd
SZSE:000725
|
CN |
|
M
|
Mabpharm Ltd
HKEX:2181
|
CN |
|
Stockland Corporation Ltd
ASX:SGP
|
AU |
|
F
|
Fujian South Highway Machinery Co Ltd
SSE:603280
|
CN |
|
E
|
Envela Corp
AMEX:ELA
|
US |
|
A
|
Alaska Hydro Corp
XTSX:AKH.H
|
CA |
|
S
|
Shanxi Blue Flame Holding Co Ltd
SZSE:000968
|
CN |
|
B
|
Bitdeer Technologies Group
NASDAQ:BTDR
|
SG |
Balance Sheet
Balance Sheet Decomposition
Otrs AG
Otrs AG
Balance Sheet
Otrs AG
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
1
|
2
|
2
|
3
|
4
|
4
|
3
|
|
| Cash Equivalents |
0
|
1
|
1
|
1
|
2
|
2
|
3
|
4
|
4
|
3
|
|
| Total Receivables |
2
|
2
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Accounts Receivables |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Other Receivables |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
2
|
2
|
3
|
3
|
4
|
4
|
6
|
7
|
5
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
1
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
2
|
|
| Goodwill |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Long-Term Investments |
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
5
N/A
|
6
+7%
|
5
-5%
|
6
+17%
|
7
+20%
|
9
+23%
|
11
+23%
|
13
+20%
|
14
+4%
|
11
-21%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Liabilities |
3
|
4
|
3
|
4
|
5
|
5
|
6
|
6
|
7
|
6
|
|
| Total Liabilities |
4
N/A
|
4
-4%
|
4
-9%
|
4
+21%
|
5
+25%
|
6
+16%
|
7
+13%
|
8
+16%
|
9
+5%
|
7
-18%
|
|
| Equity | |||||||||||
| Common Stock |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Retained Earnings |
1
|
1
|
0
|
0
|
0
|
1
|
2
|
3
|
3
|
2
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
2
+50%
|
2
+6%
|
2
+8%
|
2
+7%
|
3
+40%
|
4
+44%
|
5
+27%
|
5
+1%
|
4
-25%
|
|
| Total Liabilities & Equity |
5
N/A
|
6
+7%
|
5
-5%
|
6
+17%
|
7
+20%
|
9
+23%
|
11
+23%
|
13
+20%
|
14
+4%
|
11
-21%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|